Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Debt Ratio (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Debt Ratio for 16 consecutive years, with 0.44 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio rose 50.98% to 0.44 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.44, a 50.98% increase, with the full-year FY2024 number at 0.29, up 9.63% from a year prior.
  • Debt Ratio was 0.44 for Q3 2025 at Harvard Bioscience, roughly flat from 0.44 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.45 in Q1 2025 to a low of 0.27 in Q4 2023.
  • A 5-year average of 0.32 and a median of 0.29 in 2021 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: fell 17.37% in 2023, then soared 68.5% in 2025.
  • Harvard Bioscience's Debt Ratio stood at 0.3 in 2021, then increased by 8.2% to 0.32 in 2022, then dropped by 17.37% to 0.27 in 2023, then grew by 9.63% to 0.29 in 2024, then soared by 49.25% to 0.44 in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Debt Ratio are 0.44 (Q3 2025), 0.44 (Q2 2025), and 0.45 (Q1 2025).